Toronto Dominion Bank raised its holdings in shares of Organigram Holdings Inc. (NASDAQ:OGI – Free Report) by 803.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,727 shares of the company’s stock after purchasing an additional 14,876 shares during the quarter. Toronto Dominion Bank’s holdings in Organigram were worth $30,000 as of its most recent filing with the Securities & Exchange Commission.
Separately, AdvisorShares Investments LLC lifted its stake in shares of Organigram by 11.8% during the 2nd quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock valued at $1,540,000 after buying an additional 105,468 shares in the last quarter. 34.63% of the stock is owned by hedge funds and other institutional investors.
Organigram Trading Up 3.4 %
Organigram stock opened at $1.53 on Tuesday. The firm has a 50 day simple moving average of $1.63 and a 200 day simple moving average of $1.68. Organigram Holdings Inc. has a 1-year low of $1.21 and a 1-year high of $2.91. The firm has a market capitalization of $193.02 million, a price-to-earnings ratio of -3.65 and a beta of 1.02.
About Organigram
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Featured Articles
- Five stocks we like better than Organigram
- Profitably Trade Stocks at 52-Week Highs
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Investing in Travel Stocks Benefits
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.